Statements (55)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:healthcare_organization
|
| gptkbp:bfsLayer |
4
|
| gptkbp:bfsParent |
gptkb:Ig_G4-related_sclerosing_cholangitis
|
| gptkbp:affects |
bile ducts
|
| gptkbp:clinical_trial |
gptkb:vaccine
ongoing research targeted therapy |
| gptkbp:current_use |
gptkb:healthcare_organization
gptkb:hepatitis_C cirrhosis |
| gptkbp:end_of_life |
depends on stage
5-year survival rate low |
| gptkbp:genetic_diversity |
gptkb:physicist
ID H1 mutation |
| gptkbp:healthcare |
gptkb:MRI
CT scan ultrasound |
| https://www.w3.org/2000/01/rdf-schema#label |
cholangiocarcinoma
|
| gptkbp:is_tested_for |
gptkb:AFP
CEA CA 19-9 |
| gptkbp:number_of_stages |
stage I
stage IV stage II stage III |
| gptkbp:population |
older adults
rare in children |
| gptkbp:research_focus |
genetic studies
early detection new therapies |
| gptkbp:risk_factor |
liver fluke infection
primary sclerosing cholangitis |
| gptkbp:social_responsibility |
gptkb:healthcare_organization
biopsy imaging tests more common in men poor prognosis bile duct origin more common in Asia |
| gptkbp:symptoms |
weight loss
abdominal pain jaundice |
| gptkbp:treatment |
gptkb:hospital
palliative care liver transplant radiation therapy chemotherapy surgical complications endoscopic procedures monitoring required late diagnosis recurrence risk |
| gptkbp:type |
extrahepatic cholangiocarcinoma
intrahepatic cholangiocarcinoma perihilar cholangiocarcinoma |